{"gene":"DEAF1","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":1996,"finding":"DEAF-1 (Deformed epidermal autoregulatory factor-1) is a sequence-specific DNA-binding protein isolated from Drosophila nuclear extracts that binds a specific site in the Deformed homeotic response element, functioning as a cofactor required for Deformed-dependent transcriptional activation. Mutations improving DEAF-1 binding increased embryonic expression; mutations diminishing binding reduced expression.","method":"Protein-DNA binding assay (affinity isolation from nuclear extracts), in vitro mutagenesis of response element, reporter gene assays in Drosophila embryos","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro DNA binding with mutagenesis confirmed by in vivo reporter assays; foundational paper with multiple orthogonal methods","pmids":["8617243"],"is_preprint":false},{"year":1998,"finding":"The mammalian DEAF-1 homolog NUDR is a nuclear transcriptional regulator that binds a consensus DNA motif (TTCGGGNNTTTCCGG/TTCG core) identified by SELEX from random oligonucleotide libraries; nuclear localization depends on an NLS whose mutation causes cytoplasmic mislocalization and eliminates transcriptional activation. NUDR activates the proenkephalin promoter up to 41-fold and is displaced from RARE sequences by RAR/RXR complexes.","method":"SELEX, mobility shift assays, DNase I footprinting, site-directed mutagenesis of NLS, GFP fusion protein localization, transient transfection reporter assays, immunocytochemistry","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (SELEX, EMSA, DNase I protection, mutagenesis, reporter assays) in single study","pmids":["9773984"],"is_preprint":false},{"year":1999,"finding":"NUDR/DEAF-1 DNA binding domain was localized to amino acids 167–368 by deletion analysis; the domain contains a proline-rich region and a Myc-type HLH-like motif but not the C-terminal zinc finger. NUDR represses the hnRNP A2/B1 promoter ~65–70% through binding motifs (TTC(C/G)G) in the 5′-UTR of the hnRNP A2/B1 gene, and this repression also operates on NUDR's own 5′-UTR, suggesting autoregulation.","method":"NUDR protein deletion constructs, site-specific DNA photocrosslinking, DNase I footprinting, transient transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — deletion mapping combined with photocrosslinking, footprinting, and reporter assays; multiple orthogonal methods","pmids":["10521432"],"is_preprint":false},{"year":2002,"finding":"Drosophila DEAF-1 is required for early embryonic development: maternal/zygotic DEAF-1 mutations cause embryonic arrest prior to zygotic segmentation gene expression. DEAF-1 protein associates with many discrete sites on polytene chromosomes, indicating it is a broad regulator of gene expression. Overexpression causes defects in dorsal epidermis migration/closure and disrupts eye and wing development.","method":"Genetic loss-of-function (maternal/zygotic mutants), gain-of-function overexpression, polytene chromosome immunostaining","journal":"Genesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function and gain-of-function genetics with defined phenotypic readouts plus chromosomal localization","pmids":["12112874"],"is_preprint":false},{"year":2004,"finding":"Deaf-1 knockout mice display defects in neural tube closure (exencephaly), homeotic skeletal transformations (cervical vertebrae and rib cage), overlapping with but distinct from LMO4 knockout phenotypes, indicating that Deaf-1 and LMO4 function in a shared pathway controlling neural tube closure and anteroposterior skeletal patterning in vivo.","method":"Gene knockout in mice (Deaf-1 and Lmo4 null alleles), embryo and skeletal phenotypic analysis, genetic epistasis by overlapping phenotype comparison","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined phenotypic readout replicated in two independent knockout lines (Lmo4 and Deaf-1), epistatic relationship supported by overlapping phenotypes","pmids":["14966286"],"is_preprint":false},{"year":2004,"finding":"DEAF-1 contains a CRM1-dependent nuclear export signal (NES) with novel leucine spacing (LXLX(6)LLX(5)LX(2)L) at amino acids 454–476 adjacent to the MYND domain; mutation of key leucines or leptomycin B treatment eliminates nuclear export. A DEAF-1/DEAF-1 self-interaction domain maps to this NES region. A second protein-protein interaction domain at aa 243–306 encompasses the SAND domain and an adjacent zinc-binding motif; mutation of conserved cysteines/histidine in the zinc motif eliminates both protein interaction and DNA binding, showing protein-protein interaction is required for DNA recognition.","method":"Fluorescent fusion protein localization, leptomycin B treatment, leucine mutagenesis, in vitro GST pull-downs, in vivo fluorescent protein interaction assay, deletion mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with in vitro and in vivo interaction assays, multiple orthogonal methods in single study","pmids":["15161925"],"is_preprint":false},{"year":2006,"finding":"Deaf-1/NUDR exhibits cell-type-specific transcriptional activity at the 5-HT1A promoter C(-1019) allele: it represses transcription in serotonergic raphe RN46A cells but enhances transcription in nonserotonergic cells (SN48, SKN-SH, NG108-15). A Gal4DBD-Deaf-1 fusion protein recapitulates these opposite activities at a heterologous Gal4 element, demonstrating the activity is intrinsic to Deaf-1. Both repressor and enhancer activities require histone deacetylation (blocked by trichostatin A).","method":"Luciferase reporter assays in multiple cell lines, Gal4DBD-Deaf-1 fusion protein assays at heterologous element, trichostatin A (HDAC inhibitor) treatment","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — heterologous Gal4 domain fusion demonstrates intrinsic activity; multiple cell lines and HDAC inhibitor provide orthogonal mechanistic evidence","pmids":["16467535"],"is_preprint":false},{"year":2009,"finding":"The transcriptional regulator Deaf1 controls expression of peripheral tissue antigen (PTA) genes in pancreatic lymph node stromal cells. An alternatively spliced dominant-negative Deaf1 isoform (Deaf1-Var1) suppresses PTA expression by inhibiting canonical Deaf1 transcriptional activity, and this isoform is elevated during insulitis in NOD mice and in type 1 diabetes patients.","method":"Reporter gene assays (luciferase), siRNA knockdown, gene expression profiling, RT-PCR in mouse and human lymph node samples","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional reporter assays combined with in vivo mouse model and human patient tissue, replicated across species","pmids":["19668219"],"is_preprint":false},{"year":2009,"finding":"Drosophila Deaf1 is required for Toll-pathway-dependent innate immune responses: RNAi knockdown of Deaf1 reduces expression of the antifungal peptide gene Drosomycin and impairs survival after fungal (but not E. coli) infection. Epistasis analysis places Deaf1 downstream of the NF-κB factors Dorsal and Dif.","method":"Genome-wide RNAi screen, in vivo RNAi knockdown, survival assays after infection, genetic epistasis analysis","journal":"Journal of innate immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis combined with in vivo loss-of-function and pathogen challenge with specific phenotypic readout","pmids":["20375635"],"is_preprint":false},{"year":2012,"finding":"Deaf-1 in vivo represses 5-HT1A autoreceptor expression in dorsal raphe (serotonergic) neurons while enhancing postsynaptic 5-HT1A heteroreceptor expression in frontal cortex. Deaf-1 knockout mice have increased 5-HT1A mRNA, protein, and positive cell counts in dorsal raphe but decreased 5-HT1A in frontal cortex, and reduced serotonin levels in raphe. A functional Deaf-1 binding site on the mouse 5-HT1A promoter was confirmed by ChIP and in vitro binding.","method":"Deaf-1 knockout mice, quantitative RT-PCR, in situ hybridization, immunofluorescence, ChIP, EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with region-specific phenotypes confirmed by multiple methods (qPCR, ISH, immunofluorescence, ChIP, EMSA)","pmids":["22232550"],"is_preprint":false},{"year":2012,"finding":"DEAF1 interacts with the Ku70 (XRCC6) and Ku80 (XRCC5) subunits of the DNA-PK complex. The interaction is mediated through DEAF1's DNA binding domain and the C-terminal Bax-binding region of Ku70. DEAF1 is phosphorylated by DNA-PK in vitro in a DNA-independent manner. DEAF1 binding sites in DNA inhibit the DEAF1–Ku70 interaction, suggesting competitive regulation.","method":"GST pulldown with mass spectrometry identification, co-immunoprecipitation of epitope-tagged proteins in cells, in vitro kinase assay, EMSA","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and in vitro kinase assay in single lab; EMSA provides additional orthogonal method","pmids":["22442688"],"is_preprint":false},{"year":2012,"finding":"DEAF1 regulates translation in lymph node stromal cells by controlling transcription of Eif4g3 (encoding eIF4GII). Deaf1 KO and Deaf1 silencing reduce Eif4g3 expression and increase Caspase-3-mediated eIF4GII degradation; reduced eIF4GII leads to diminished polysomal translation of multiple genes including Anpep.","method":"Deaf-1 knockout mice, siRNA silencing, RT-PCR, polysome profiling, western blotting","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO and siRNA knockdown with polysome profiling as functional readout; single lab","pmids":["22923498"],"is_preprint":false},{"year":2013,"finding":"The solution NMR structure of the human DEAF-1 MYND domain (residues 501–544) reveals a ββα fold with tandem zinc-binding sites in a cross-brace topology. The MYND domain binds peptides derived from SMRT and NCoR corepressors; the binding surface mapped by NMR titrations is similar to that of AML1/ETO MYND domain, demonstrating DEAF-1 recruits corepressors through this domain.","method":"NMR spectroscopy (solution structure determination), NMR titration mapping of binding surface, peptide binding assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional validation of ligand binding; multiple orthogonal NMR methods in single rigorous study","pmids":["23372760"],"is_preprint":false},{"year":2013,"finding":"DEAF1 is a Pellino1-interacting protein required for IFNβ production. DEAF1 binds the IFNβ promoter and interacts with IRF3 and IRF7. DEAF1 is required for IFNβ transcription and secretion in MEFs infected with Sendai virus or transfected with poly(I:C), and for TLR3-dependent IFNβ production. The Pellino1–DEAF1 interaction is independent of Pellino1 E3 ligase activity but is weakened by Pellino1 phosphorylation.","method":"Co-immunoprecipitation (Pellino1–DEAF1 interaction), ChIP (DEAF1 on IFNβ promoter), co-IP of DEAF1 with IRF3/IRF7, siRNA knockdown of DEAF1, ELISA for IFNβ secretion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ChIP, and siRNA KD with functional IFNβ output; multiple orthogonal methods in single study","pmids":["23846693"],"is_preprint":false},{"year":2012,"finding":"A specific LMO4-binding domain in DEAF1 contains an intrinsically disordered region that directly contacts LMO4, flanked by a coiled-coil region containing the NES. The coiled-coil region can form tetramers. LMO4 modulates DEAF1 NES activity, causing nuclear accumulation of a construct containing the LMO4-interaction region of DEAF1.","method":"GST pulldowns, cell-based nuclear export assay, coiled-coil characterization","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping by pulldown plus cell-based functional assay; single lab","pmids":["22723967"],"is_preprint":false},{"year":2014,"finding":"The NMR solution structure of the LMO4 LIM2–DEAF1 complex shows that the intrinsically disordered LMO4-binding domain of DEAF1 becomes structured upon binding LMO4 LIM2. Yeast two-hybrid and mutagenic analysis show DEAF1 binds both LIM domains of LMO4 at the same face used by LDB1 and CtIP/RBBP8, revealing LMO4 as a competitive hub in protein interaction networks.","method":"NMR spectroscopy (solution structure of tethered complex), yeast two-hybrid, mutagenic scanning","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with mutagenic validation and yeast two-hybrid; multiple orthogonal methods in single study","pmids":["25310299"],"is_preprint":false},{"year":2014,"finding":"DEAF1 preferentially binds variably spaced (6–11 nt apart), unmethylated dual CpG dinucleotide motifs (repeated TTCGGG half-sites). Cytosine methylation of a single CpG half-site or alteration of the surrounding consensus eliminates DEAF1 binding. ChIP assay confirmed endogenous DEAF1 binds the EIF4G3 promoter at a sequence matching this consensus.","method":"SELEX with anchored CpG motif, EMSA, ChIP assay for endogenous DEAF1 at EIF4G3 promoter","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SELEX-defined consensus validated by EMSA and ChIP; multiple orthogonal methods in single study","pmids":["25531106"],"is_preprint":false},{"year":2014,"finding":"All four identified de novo DEAF1 missense mutations in intellectual disability patients affect the SAND domain and impair DEAF1-dependent transcriptional regulation of the DEAF1 promoter in reporter assays. Conditional brain-specific Deaf1 knockout mice display memory deficits and increased anxiety-like behavior, establishing that SAND domain-mediated transcriptional activity is required for normal cognitive function.","method":"Luciferase reporter assays (DEAF1 promoter), conditional Deaf1 brain knockout mice (behavioral phenotyping), clinical exome sequencing","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reporter assays combined with conditional KO behavioral phenotype; replicated across four independent de novo variants","pmids":["24726472"],"is_preprint":false},{"year":2014,"finding":"Inflammation and hyperglycemia independently drive alternative splicing of Deaf1 to the dominant-negative Deaf1-Var1 isoform in pancreatic lymph node stromal cells via distinct splicing factors: inflammation activates Srsf10 and hyperglycemia activates Ptbp2. Overexpression of PTBP2 and/or SRSF10 increases human DEAF1-VAR1 and reduces PTA expression.","method":"In vivo NOD mouse models (splenocyte injection, S961 insulin receptor agonist), RT-PCR for isoforms, overexpression of splicing factors in HEK293T cells, reporter assays","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo manipulation with splicing factor overexpression provides mechanistic pathway; single lab","pmids":["25187368"],"is_preprint":false},{"year":2017,"finding":"De novo DEAF1 missense variants in the SAND domain (e.g., p.Gly212Ser) reduce DEAF1 transcriptional repression at the DEAF1 promoter and reduce affinity to consensus DEAF1 DNA binding sequences. A NLS domain deletion variant (p.Lys305del) localizes primarily to the cytoplasm and interacts with wild-type DEAF1, consistent with dominant-negative activity via cytoplasmic sequestration.","method":"Luciferase reporter assays, immunofluorescence localization, EMSA","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays, EMSA, and localization provide three orthogonal methods; single lab","pmids":["28940898"],"is_preprint":false},{"year":2023,"finding":"De novo heterozygous DEAF1 variants within the DNA binding domain act as dominant negatives: cells overexpressing de novo variants show gene expression profiles similar to CRISPR-Cas9-mediated DEAF1 deletion. Wild-type DEAF1 rescues altered gene expression in DEAF1-deleted cells whereas de novo variants do not. Loss of Deaf1 in mouse hippocampus reduces dendritic spine density.","method":"RNA-sequencing of conditional Deaf1 KO mouse hippocampus, CRISPR-Cas9 DEAF1 deletion, overexpression rescue assays, dendritic spine imaging","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative mechanism established by rescue assay in DEAF1-null background; single lab with multiple cell models","pmids":["35981081"],"is_preprint":false},{"year":2024,"finding":"DEAF1 is a FOXO-regulated transcription factor that suppresses autophagy by binding the Pik3c3 and Atg16l1 promoters and repressing their expression. DEAF1 depletion induces autophagy and impairs muscle stem cell (MuSC) survival and differentiation; DEAF1 overexpression inactivates autophagy causing protein aggregation and cell death. DEAF1 is elevated in aged and cachectic MuSCs, and its manipulation attenuates muscle atrophy.","method":"ChIP (DEAF1 binding to Pik3c3 and Atg16l1 promoters), DEAF1 depletion and overexpression in MuSCs, autophagy flux assays, in vivo mouse models (aging, cancer cachexia)","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-confirmed direct promoter binding combined with loss- and gain-of-function in vitro and in vivo with autophagy-specific functional readouts","pmids":["38963021"],"is_preprint":false},{"year":2025,"finding":"DEAF1 acts as a key upstream driver of mTORC1 in aged skeletal muscle by increasing mTOR transcription. Elevated DEAF1 leads to impaired proteostasis and muscle senescence; exercise suppresses DEAF1 via FOXO activation, restoring mTORC1 balance. FOXO inhibition or Deaf1 overexpression blocks exercise-mediated restoration of muscle health.","method":"Deaf1 overexpression and depletion in mouse muscle, mTOR transcription reporter assays, mTORC1 activity measurements, FOXO inhibition, exercise intervention in mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function in vivo with mTORC1 activity readout; single lab","pmids":["41284871"],"is_preprint":false},{"year":2025,"finding":"DEAF1 directly binds the RAD50 promoter via its SAND domain, upregulating RAD50 and activating the ATM DNA damage repair pathway. DEAF1 also recruits AP-2α through its MYND domain, leading to downregulation of FER tyrosine kinase, which impairs FER-mediated phosphorylation of GSDME and suppresses GSDME cleavage by caspase-3, thereby attenuating pyroptosis in multiple myeloma.","method":"ChIP (DEAF1 binding to RAD50 promoter via SAND domain), co-immunoprecipitation (DEAF1–AP-2α via MYND domain), high-throughput sequencing of DEAF1 targets, in vivo and in vitro functional assays","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with functional pathway readouts; single lab, novel mechanistic claims","pmids":["41421151"],"is_preprint":false},{"year":2023,"finding":"GSK3β phosphorylates DEAF1 and modulates its repressor activity at the 5-HT1A promoter. Lithium and selective GSK3 inhibitors (CHIR-99021, AR-014418) attenuate and reverse Deaf1-mediated repression of 5-HT1A transcription at concentrations that maximally inhibit GSK3β. The Y300F point mutation in Deaf1 augments its repressor function, while other predicted phosphorylation site mutants had no effect.","method":"Luciferase reporter assays (5-HT1A promoter), GSK3β inhibitor treatments, site-directed mutagenesis of DEAF1 phosphorylation sites, TCF/LEF reporter for GSK3β activity","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis and pharmacological inhibition with reporter assays; indirect kinase evidence without direct in vitro phosphorylation shown in abstract","pmids":["37958600"],"is_preprint":false},{"year":2025,"finding":"DEAF1 interacts with the transcriptional coactivator SAYP (a component of the Brahma chromatin remodeling complex) via immunoprecipitation; specific domains mediating their association were mapped. SAYP and DEAF1 are co-recruited to antimicrobial peptide (AMP) gene regions in a gene- and pathogen-specific manner in Drosophila S2 cells after immune challenge.","method":"Immunoprecipitation (SAYP–DEAF1 interaction), domain mapping, ChIP for recruitment to AMP gene loci, RNAi knockdown of SAYP and DEAF1","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping and ChIP showing co-recruitment; single study in Drosophila cell model","pmids":["41862015"],"is_preprint":false}],"current_model":"DEAF1/NUDR is a sequence-specific transcription factor that binds unmethylated dual CpG-containing DNA motifs (TTCG/TTCGGG core) through its SAND domain, recruits corepressors (NCoR, SMRT) via its MYND domain (which has a defined ββα zinc-binding fold), interacts with LMO4, Ku70/DNA-PK, IRF3/IRF7, Pellino1, AP-2α, and SAYP, and acts as a cell-context-dependent repressor or enhancer of target gene transcription (including 5-HT1A receptor, hnRNP A2/B1, Eif4g3, Pik3c3, Atg16l1, RAD50, and mTOR); its activity is regulated by nuclear-cytoplasmic shuttling (via a CRM1-dependent NES and NLS), phosphorylation by GSK3β and DNA-PK, alternative splicing to a dominant-negative isoform, and upstream FOXO-mediated transcriptional repression, placing it at the intersection of neurodevelopment, peripheral immune tolerance, innate immunity, serotonergic neurotransmission, autophagy, and mTORC1-driven muscle aging."},"narrative":{"mechanistic_narrative":"DEAF1 (NUDR) is a sequence-specific transcription factor that controls programs in neurodevelopment, immune tolerance, innate immunity, serotonergic signaling, and muscle homeostasis [PMID:8617243, PMID:9773984, PMID:19668219, PMID:38963021]. It recognizes unmethylated dual CpG-containing motifs built from repeated TTCGGG half-sites variably spaced 6–11 nt apart, and methylation of a single half-site abolishes binding [PMID:9773984, PMID:25531106]. DNA recognition is conferred by the SAND domain region; the adjacent zinc-binding motif couples protein-protein interaction to DNA binding, and a CRM1-dependent nuclear export signal together with an NLS govern its nuclear-cytoplasmic distribution [PMID:15161925, PMID:28940898]. A solved MYND domain adopts a ββα fold with cross-brace zinc sites that binds NCoR and SMRT corepressor peptides, providing the structural basis for transcriptional repression, which depends on histone deacetylation [PMID:23372760, PMID:16467535]. DEAF1 acts as a cell-context-dependent repressor or activator: it represses the hnRNP A2/B1 promoter and its own promoter, represses the 5-HT1A autoreceptor in raphe neurons while enhancing it in non-serotonergic cells, and controls peripheral tissue antigen expression in lymph node stromal cells, where an alternatively spliced dominant-negative isoform (Deaf1-Var1) suppresses its activity [PMID:10521432, PMID:16467535, PMID:19668219, PMID:22232550]. Through an intrinsically disordered region that becomes structured on binding LMO4 LIM domains, DEAF1 engages LMO4 as a competitive interaction hub that modulates its nuclear export [PMID:22723967, PMID:25310299]. In innate immunity it binds the IFNβ promoter and interacts with IRF3/IRF7 and Pellino1 to drive antiviral IFNβ production [PMID:23846693]. In muscle, DEAF1 is a FOXO-regulated factor that represses the autophagy genes Pik3c3 and Atg16l1 and drives mTOR transcription, becoming elevated in aged and cachectic muscle stem cells [PMID:38963021, PMID:41284871]. De novo SAND-domain and NLS missense/deletion variants cause an intellectual disability disorder by impairing DNA binding and transcriptional regulation and acting as dominant negatives, with conditional brain knockout mice showing memory deficits, anxiety, and reduced dendritic spine density [PMID:24726472, PMID:28940898, PMID:35981081].","teleology":[{"year":1996,"claim":"Established DEAF1 as a sequence-specific DNA-binding cofactor by showing it binds a defined site in the Deformed homeotic response element and is required for Deformed-dependent activation.","evidence":"Affinity isolation from Drosophila nuclear extracts with response-element mutagenesis and embryonic reporter assays","pmids":["8617243"],"confidence":"High","gaps":["Mammalian role not addressed","Domain responsible for binding not yet mapped"]},{"year":1998,"claim":"Defined the mammalian DEAF1/NUDR consensus motif and showed nuclear localization is required for transcriptional activity, framing it as a regulated nuclear transcription factor.","evidence":"SELEX, EMSA, DNase I footprinting, NLS mutagenesis and reporter assays","pmids":["9773984"],"confidence":"High","gaps":["Endogenous target genes not yet identified","Mechanism of activation vs repression unresolved"]},{"year":1999,"claim":"Localized the DNA-binding domain by deletion mapping and demonstrated DEAF1 represses the hnRNP A2/B1 promoter and its own 5'-UTR, introducing autoregulation.","evidence":"Deletion constructs, photocrosslinking, footprinting and reporter assays","pmids":["10521432"],"confidence":"High","gaps":["Corepressor machinery not identified","Structural basis of binding unknown"]},{"year":2002,"claim":"Showed DEAF1 is essential for early development and broadly chromatin-associated, expanding it from a single-gene cofactor to a global regulator.","evidence":"Drosophila loss/gain-of-function genetics and polytene chromosome immunostaining","pmids":["12112874"],"confidence":"High","gaps":["Direct target genes in vivo undefined","Mammalian developmental role not tested here"]},{"year":2004,"claim":"Defined the in vivo mammalian developmental role and a shared pathway with LMO4 in neural tube closure and skeletal patterning.","evidence":"Deaf-1 and Lmo4 knockout mice with embryo and skeletal phenotyping","pmids":["14966286"],"confidence":"High","gaps":["Molecular nature of Deaf1-LMO4 interaction not yet structural","Target genes mediating phenotypes unknown"]},{"year":2004,"claim":"Resolved domain architecture controlling localization and DNA binding, showing a CRM1-dependent NES, a self-interaction region, and that protein interaction at the SAND/zinc motif is required for DNA recognition.","evidence":"Fusion protein localization, leptomycin B, leucine/cysteine mutagenesis, GST pulldowns and in vivo interaction assays","pmids":["15161925"],"confidence":"High","gaps":["Physiological partners at the interaction domain not all identified","Regulation of shuttling not linked to signaling"]},{"year":2006,"claim":"Demonstrated that DEAF1 transcriptional activity is intrinsic and cell-type-dependent (repressor vs enhancer) at the 5-HT1A promoter and requires histone deacetylation.","evidence":"Multi-cell-line luciferase assays, Gal4DBD fusion at heterologous element, trichostatin A treatment","pmids":["16467535"],"confidence":"High","gaps":["Identity of cell-type-specific cofactors switching activity unknown","In vivo serotonergic consequence not yet shown"]},{"year":2009,"claim":"Identified DEAF1 control of peripheral tissue antigen expression in lymph node stroma and a dominant-negative splice isoform elevated in autoimmune diabetes, linking it to immune tolerance.","evidence":"Reporter assays, siRNA, expression profiling and RT-PCR in mouse and human tissue","pmids":["19668219"],"confidence":"High","gaps":["Splicing regulation of Var1 not yet defined","Direct PTA promoter targets not all mapped"]},{"year":2009,"claim":"Placed Drosophila Deaf1 downstream of NF-κB factors in Toll-dependent antifungal immunity, establishing an innate immune function.","evidence":"Genome-wide RNAi screen, in vivo knockdown, infection survival and epistasis","pmids":["20375635"],"confidence":"High","gaps":["Mammalian innate immune role not addressed here","Mechanism of antimicrobial gene induction unknown"]},{"year":2012,"claim":"Mapped the LMO4-binding region as an intrinsically disordered segment flanked by a tetramer-forming coiled-coil, and showed LMO4 modulates DEAF1 nuclear export.","evidence":"GST pulldowns, cell-based export assay and coiled-coil characterization","pmids":["22723967"],"confidence":"Medium","gaps":["Structural detail of complex not yet resolved","Single lab"]},{"year":2012,"claim":"Connected DEAF1 to the DNA-PK machinery, showing Ku70/Ku80 binding and DNA-PK phosphorylation of DEAF1 with DNA competing for the interaction.","evidence":"GST pulldown/MS, reciprocal Co-IP, in vitro kinase assay and EMSA","pmids":["22442688"],"confidence":"Medium","gaps":["Functional consequence of phosphorylation unresolved","Single lab without in vivo validation"]},{"year":2012,"claim":"Defined a downstream translational output of DEAF1 by showing it transcriptionally controls Eif4g3/eIF4GII and thereby polysomal translation in lymph node stroma.","evidence":"Knockout/siRNA, RT-PCR, polysome profiling and western blot","pmids":["22923498"],"confidence":"Medium","gaps":["Generality beyond stromal cells unknown","Single lab"]},{"year":2012,"claim":"Linked DEAF1 to serotonergic neurotransmission in vivo, showing region-specific repression of the 5-HT1A autoreceptor and enhancement of the heteroreceptor.","evidence":"Knockout mice with qPCR, ISH, immunofluorescence, ChIP and EMSA","pmids":["22232550"],"confidence":"High","gaps":["Behavioral/affective consequences not directly tested","Switch mechanism between brain regions unresolved"]},{"year":2013,"claim":"Provided the MYND domain structure and showed it recruits NCoR/SMRT corepressors, defining the structural basis of DEAF1 repression.","evidence":"Solution NMR structure, titration mapping and peptide binding","pmids":["23372760"],"confidence":"High","gaps":["Corepressor recruitment not validated on endogenous targets","Activator mechanism still unexplained"]},{"year":2013,"claim":"Established a positive innate immune role in mammals, with DEAF1 binding the IFNβ promoter and partnering IRF3/IRF7 and Pellino1 to drive IFNβ production.","evidence":"Reciprocal Co-IP, ChIP, siRNA and IFNβ ELISA in virus/poly(I:C)-challenged MEFs","pmids":["23846693"],"confidence":"High","gaps":["Role of Pellino1 phosphorylation in vivo not resolved","How DEAF1 cooperates with IRFs structurally unknown"]},{"year":2014,"claim":"Solved the LMO4 LIM2–DEAF1 complex, showing disorder-to-order folding on binding and that DEAF1 competes with LDB1 and CtIP for LMO4, defining LMO4 as a shared interaction hub.","evidence":"NMR structure of tethered complex, yeast two-hybrid and mutagenic scanning","pmids":["25310299"],"confidence":"High","gaps":["Functional outcome of LMO4 competition on target genes unknown"]},{"year":2014,"claim":"Refined the DNA recognition code to variably spaced unmethylated dual CpG motifs, establishing methylation sensitivity and an endogenous EIF4G3 target.","evidence":"Anchored-CpG SELEX, EMSA and ChIP at the EIF4G3 promoter","pmids":["25531106"],"confidence":"High","gaps":["Genome-wide occupancy not mapped","Link of methylation sensitivity to physiology untested"]},{"year":2014,"claim":"Established DEAF1 as an intellectual disability gene, with SAND-domain de novo missense variants impairing transcriptional activity and brain-specific knockout causing cognitive deficits.","evidence":"Exome sequencing, reporter assays and conditional brain knockout behavioral phenotyping","pmids":["24726472"],"confidence":"High","gaps":["Precise neuronal targets driving cognition unknown","Dominant vs recessive mechanism not yet resolved"]},{"year":2014,"claim":"Defined how the dominant-negative Deaf1-Var1 isoform is generated, identifying inflammation- and hyperglycemia-driven splicing via Srsf10 and Ptbp2.","evidence":"NOD mouse models, isoform RT-PCR and splicing factor overexpression with reporters","pmids":["25187368"],"confidence":"Medium","gaps":["Direct splicing factor binding sites not mapped","Single lab"]},{"year":2017,"claim":"Extended the disease mechanism by showing SAND-domain variants reduce DNA-binding affinity and an NLS deletion variant sequesters DEAF1 in the cytoplasm and binds wild-type protein, supporting dominant-negative action.","evidence":"Reporter assays, EMSA and immunofluorescence localization","pmids":["28940898"],"confidence":"Medium","gaps":["Dominant-negative effect not yet shown at endogenous targets","Single lab"]},{"year":2023,"claim":"Confirmed the dominant-negative mechanism transcriptome-wide, showing de novo DNA-binding-domain variants phenocopy DEAF1 deletion and fail to rescue, and linked Deaf1 loss to reduced dendritic spine density.","evidence":"Conditional KO hippocampal RNA-seq, CRISPR deletion, rescue assays and spine imaging","pmids":["35981081"],"confidence":"Medium","gaps":["Causal target genes for spine phenotype not pinpointed","Single lab"]},{"year":2023,"claim":"Added phospho-regulation of DEAF1 by GSK3β at the 5-HT1A promoter, with GSK3 inhibitors reversing repression and the Y300F mutant augmenting repressor function.","evidence":"Reporter assays with GSK3 inhibitors and phosphosite mutagenesis","pmids":["37958600"],"confidence":"Medium","gaps":["Direct in vitro phosphorylation not demonstrated","In vivo relevance to behavior untested"]},{"year":2024,"claim":"Defined DEAF1 as a FOXO-regulated autophagy repressor that directly represses Pik3c3 and Atg16l1, controlling muscle stem cell survival and elevated in aging and cachexia.","evidence":"ChIP, loss/gain-of-function in MuSCs, autophagy flux assays and in vivo aging/cachexia models","pmids":["38963021"],"confidence":"High","gaps":["FOXO–DEAF1 promoter regulation not structurally defined","Single lab"]},{"year":2025,"claim":"Positioned DEAF1 as an upstream driver of mTORC1 in aged muscle by increasing mTOR transcription, with exercise suppressing it via FOXO to restore proteostasis.","evidence":"Deaf1 gain/loss in muscle, mTOR reporter and mTORC1 activity assays, FOXO inhibition and exercise intervention","pmids":["41284871"],"confidence":"Medium","gaps":["Direct DEAF1 occupancy of the mTOR promoter not shown","Single lab"]},{"year":2025,"claim":"Revealed a cancer-relevant dual function in which SAND-mediated RAD50 activation engages ATM repair while MYND-mediated AP-2α recruitment suppresses GSDME pyroptosis in multiple myeloma.","evidence":"ChIP, Co-IP, high-throughput target sequencing and functional assays in vitro and in vivo","pmids":["41421151"],"confidence":"Medium","gaps":["Generality beyond multiple myeloma unknown","Single lab with novel claims"]},{"year":2025,"claim":"Connected DEAF1 to a chromatin remodeling coactivator, showing SAYP (Brahma complex) interaction and pathogen-specific co-recruitment to antimicrobial peptide loci.","evidence":"Co-IP with domain mapping, ChIP and RNAi in Drosophila S2 cells","pmids":["41862015"],"confidence":"Medium","gaps":["Mammalian conservation of SAYP interaction untested","Single study"]},{"year":null,"claim":"How a single sequence-specific factor switches between repressor and activator outputs across cell types and biological processes remains the central open question.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No genome-wide occupancy map integrating contexts","Cofactor switch governing activation vs repression undefined","Integration of phosphorylation, splicing, and shuttling into a unified regulatory model lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,6,7,9,17,21]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,2,16,17,19]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[12,15]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,6,9,16,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,13]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[21]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,17,20]}],"complexes":[],"partners":["LMO4","XRCC6","XRCC5","IRF3","IRF7","PELI1","TFAP2A","NCOR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75398","full_name":"Deformed epidermal autoregulatory factor 1 homolog","aliases":["Nuclear DEAF-1-related transcriptional regulator","NUDR","Suppressin","Zinc finger MYND domain-containing protein 5"],"length_aa":565,"mass_kda":59.3,"function":"Transcription factor that binds to sequence with multiple copies of 5'-TTC[CG]G-3' present in its own promoter and that of the HNRPA2B1 gene. Down-regulates transcription of these genes. Binds to the retinoic acid response element (RARE) 5'-AGGGTTCACCGAAAGTTCA-3'. Activates the proenkephalin gene independently of promoter binding, probably through protein-protein interaction. When secreted, behaves as an inhibitor of cell proliferation, by arresting cells in the G0 or G1 phase. Required for neural tube closure and skeletal patterning. Regulates epithelial cell proliferation and side-branching in the mammary gland. Controls the expression of peripheral tissue antigens in pancreatic lymph nodes. Isoform 1 displays greater transcriptional activity than isoform 4. Isoform 4 may inhibit transcriptional activity of isoform 1 by interacting with isoform 1 and retaining it in the cytoplasm. Transcriptional activator of EIF4G3","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/O75398/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DEAF1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DEAF1","total_profiled":1310},"omim":[{"mim_id":"617171","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS","url":"https://www.omim.org/entry/617171"},{"mim_id":"615828","title":"VULTO-VAN SILFHOUT-DE VRIES SYNDROME; VSVS","url":"https://www.omim.org/entry/615828"},{"mim_id":"611424","title":"ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19; ZMYND19","url":"https://www.omim.org/entry/611424"},{"mim_id":"608668","title":"ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11","url":"https://www.omim.org/entry/608668"},{"mim_id":"602635","title":"DEAF1 TRANSCRIPTION FACTOR; DEAF1","url":"https://www.omim.org/entry/602635"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":42.8}],"url":"https://www.proteinatlas.org/search/DEAF1"},"hgnc":{"alias_symbol":["NUDR","SPN","ZMYND5"],"prev_symbol":[]},"alphafold":{"accession":"O75398","domains":[{"cath_id":"3.10.390.10","chopping":"198-270","consensus_level":"high","plddt":91.6562,"start":198,"end":270},{"cath_id":"-","chopping":"504-538","consensus_level":"medium","plddt":92.184,"start":504,"end":538},{"cath_id":"1.20.5","chopping":"467-502","consensus_level":"medium","plddt":91.9956,"start":467,"end":502}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75398","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75398-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75398-F1-predicted_aligned_error_v6.png","plddt_mean":60.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DEAF1","jax_strain_url":"https://www.jax.org/strain/search?query=DEAF1"},"sequence":{"accession":"O75398","fasta_url":"https://rest.uniprot.org/uniprotkb/O75398.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75398/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75398"}},"corpus_meta":[{"pmid":"8617243","id":"PMC_8617243","title":"DEAF-1, a novel protein that binds an essential region in a Deformed response element.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8617243","citation_count":126,"is_preprint":false},{"pmid":"19668219","id":"PMC_19668219","title":"Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes.","date":"2009","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19668219","citation_count":116,"is_preprint":false},{"pmid":"16467535","id":"PMC_16467535","title":"Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16467535","citation_count":110,"is_preprint":false},{"pmid":"14966286","id":"PMC_14966286","title":"Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14966286","citation_count":105,"is_preprint":false},{"pmid":"18561871","id":"PMC_18561871","title":"Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.","date":"2008","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18561871","citation_count":78,"is_preprint":false},{"pmid":"9773984","id":"PMC_9773984","title":"Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein.","date":"1998","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9773984","citation_count":76,"is_preprint":false},{"pmid":"22232550","id":"PMC_22232550","title":"Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22232550","citation_count":70,"is_preprint":false},{"pmid":"24726472","id":"PMC_24726472","title":"Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.","date":"2014","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24726472","citation_count":59,"is_preprint":false},{"pmid":"10521432","id":"PMC_10521432","title":"Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10521432","citation_count":51,"is_preprint":false},{"pmid":"12112874","id":"PMC_12112874","title":"DEAF-1 function is essential for the early embryonic development of Drosophila.","date":"2002","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12112874","citation_count":46,"is_preprint":false},{"pmid":"20375635","id":"PMC_20375635","title":"A large-scale RNAi screen identifies Deaf1 as a regulator of innate immune responses in Drosophila.","date":"2009","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20375635","citation_count":39,"is_preprint":false},{"pmid":"20026183","id":"PMC_20026183","title":"Chronic social defeat downregulates the 5-HT1A receptor but not Freud-1 or NUDR in the rat prefrontal cortex.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20026183","citation_count":37,"is_preprint":false},{"pmid":"22923498","id":"PMC_22923498","title":"Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.","date":"2012","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22923498","citation_count":35,"is_preprint":false},{"pmid":"18826651","id":"PMC_18826651","title":"Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18826651","citation_count":30,"is_preprint":false},{"pmid":"30923367","id":"PMC_30923367","title":"De novo and biallelic DEAF1 variants cause a phenotypic spectrum.","date":"2019","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30923367","citation_count":29,"is_preprint":false},{"pmid":"23846693","id":"PMC_23846693","title":"DEAF1 is a Pellino1-interacting protein required for interferon production by Sendai virus and double-stranded RNA.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23846693","citation_count":28,"is_preprint":false},{"pmid":"15161925","id":"PMC_15161925","title":"Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1).","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15161925","citation_count":28,"is_preprint":false},{"pmid":"26048982","id":"PMC_26048982","title":"Recessive DEAF1 mutation associates with autism, intellectual disability, basal ganglia dysfunction and epilepsy.","date":"2015","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26048982","citation_count":26,"is_preprint":false},{"pmid":"24946016","id":"PMC_24946016","title":"Stress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1.","date":"2014","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24946016","citation_count":25,"is_preprint":false},{"pmid":"27488351","id":"PMC_27488351","title":"Sex-dependent adaptive changes in serotonin-1A autoreceptor function and anxiety in Deaf1-deficient mice.","date":"2016","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/27488351","citation_count":24,"is_preprint":false},{"pmid":"28940898","id":"PMC_28940898","title":"Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype.","date":"2017","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/28940898","citation_count":23,"is_preprint":false},{"pmid":"23372760","id":"PMC_23372760","title":"Structural and functional analysis of the DEAF-1 and BS69 MYND domains.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23372760","citation_count":22,"is_preprint":false},{"pmid":"22723967","id":"PMC_22723967","title":"Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22723967","citation_count":21,"is_preprint":false},{"pmid":"24668509","id":"PMC_24668509","title":"Novel homozygous DEAF1 variant suspected in causing white matter disease, intellectual disability, and microcephaly.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24668509","citation_count":20,"is_preprint":false},{"pmid":"25187368","id":"PMC_25187368","title":"Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25187368","citation_count":19,"is_preprint":false},{"pmid":"38963021","id":"PMC_38963021","title":"FOXO-regulated DEAF1 controls muscle regeneration through autophagy.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38963021","citation_count":18,"is_preprint":false},{"pmid":"22442688","id":"PMC_22442688","title":"Deformed epidermal autoregulatory factor-1 (DEAF1) interacts with the Ku70 subunit of the DNA-dependent protein kinase complex.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22442688","citation_count":13,"is_preprint":false},{"pmid":"25531106","id":"PMC_25531106","title":"DEAF1 binds unmethylated and variably spaced CpG dinucleotide motifs.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25531106","citation_count":12,"is_preprint":false},{"pmid":"22328058","id":"PMC_22328058","title":"17β-estradiol-induced regulation of the novel 5-HT1A-related transcription factors NUDR and Freud-1 in SH SY5Y cells.","date":"2012","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22328058","citation_count":12,"is_preprint":false},{"pmid":"26834045","id":"PMC_26834045","title":"Identification of a syndrome comprising microcephaly and intellectual disability but not white matter disease associated with a homozygous c.676C>T p.R226W DEAF1 mutation.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26834045","citation_count":12,"is_preprint":false},{"pmid":"25310299","id":"PMC_25310299","title":"The structure of an LIM-only protein 4 (LMO4) and Deformed epidermal autoregulatory factor-1 (DEAF1) complex reveals a common mode of binding to LMO4.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25310299","citation_count":10,"is_preprint":false},{"pmid":"31783086","id":"PMC_31783086","title":"Impaired memory and marble burying activity in deformed epidermal autoregulatory factor 1 (Deaf1) conditional knockout mice.","date":"2019","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31783086","citation_count":8,"is_preprint":false},{"pmid":"35981081","id":"PMC_35981081","title":"Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders.","date":"2023","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35981081","citation_count":7,"is_preprint":false},{"pmid":"36520265","id":"PMC_36520265","title":"Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis.","date":"2022","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36520265","citation_count":7,"is_preprint":false},{"pmid":"33705764","id":"PMC_33705764","title":"De novo variants of DEAF1 cause intellectual disability in six Chinese patients.","date":"2021","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33705764","citation_count":4,"is_preprint":false},{"pmid":"38073621","id":"PMC_38073621","title":"Vulto-van Silfhout-de Vries syndrome caused by de novo variants of DEAF1 gene: a case report and literature review.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38073621","citation_count":4,"is_preprint":false},{"pmid":"23417771","id":"PMC_23417771","title":"Backbone and side-chain assignments of a tethered complex between LMO4 and DEAF-1.","date":"2013","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/23417771","citation_count":4,"is_preprint":false},{"pmid":"41284871","id":"PMC_41284871","title":"Exercise suppresses DEAF1 to normalize mTORC1 activity and reverse muscle aging.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/41284871","citation_count":3,"is_preprint":false},{"pmid":"37958600","id":"PMC_37958600","title":"Transcriptional Regulation of the Human 5-HT1A Receptor Gene by Lithium: Role of Deaf1 and GSK3β.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37958600","citation_count":2,"is_preprint":false},{"pmid":"40554679","id":"PMC_40554679","title":"Integrated functional genomics-identified DEAF1 in oxidative stress and hepatocellular carcinoma development.","date":"2025","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/40554679","citation_count":1,"is_preprint":false},{"pmid":"41456123","id":"PMC_41456123","title":"DEAF1 - a transcriptional brake on muscle autophagy.","date":"2025","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/41456123","citation_count":1,"is_preprint":false},{"pmid":"41421151","id":"PMC_41421151","title":"DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma.","date":"2025","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/41421151","citation_count":0,"is_preprint":false},{"pmid":"39172073","id":"PMC_39172073","title":"Sleep disturbances associated with DEAF1 pathogenic variants.","date":"2025","source":"Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39172073","citation_count":0,"is_preprint":false},{"pmid":"41862015","id":"PMC_41862015","title":"Transcription coactivator SAYP cooperates with transcription factor DEAF1 to mediate immune defense in Drosophila melanogaster.","date":"2026","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/41862015","citation_count":0,"is_preprint":false},{"pmid":"41518091","id":"PMC_41518091","title":"The First Reported Case of an Inherited Pathogenic Variant in DEAF1 From a Parent With Milder Phenotype Provides Evidence of Variable Gene Expressivity of the DEAF1-Associated Vulto-van Silfout-de Vries Syndrome (VSVS).","date":"2026","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/41518091","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.01.25337099","title":"A versatile data repository for GWAS summary statistics-based downstream genomic analysis of human complex traits","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.01.25337099","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.25.614184","title":"A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation","date":"2024-09-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.25.614184","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24629,"output_tokens":7246,"usd":0.091288,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16600,"output_tokens":6725,"usd":0.125562,"stage2_stop_reason":"end_turn"},"total_usd":0.21685,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"DEAF-1 (Deformed epidermal autoregulatory factor-1) is a sequence-specific DNA-binding protein isolated from Drosophila nuclear extracts that binds a specific site in the Deformed homeotic response element, functioning as a cofactor required for Deformed-dependent transcriptional activation. Mutations improving DEAF-1 binding increased embryonic expression; mutations diminishing binding reduced expression.\",\n      \"method\": \"Protein-DNA binding assay (affinity isolation from nuclear extracts), in vitro mutagenesis of response element, reporter gene assays in Drosophila embryos\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro DNA binding with mutagenesis confirmed by in vivo reporter assays; foundational paper with multiple orthogonal methods\",\n      \"pmids\": [\"8617243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The mammalian DEAF-1 homolog NUDR is a nuclear transcriptional regulator that binds a consensus DNA motif (TTCGGGNNTTTCCGG/TTCG core) identified by SELEX from random oligonucleotide libraries; nuclear localization depends on an NLS whose mutation causes cytoplasmic mislocalization and eliminates transcriptional activation. NUDR activates the proenkephalin promoter up to 41-fold and is displaced from RARE sequences by RAR/RXR complexes.\",\n      \"method\": \"SELEX, mobility shift assays, DNase I footprinting, site-directed mutagenesis of NLS, GFP fusion protein localization, transient transfection reporter assays, immunocytochemistry\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (SELEX, EMSA, DNase I protection, mutagenesis, reporter assays) in single study\",\n      \"pmids\": [\"9773984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NUDR/DEAF-1 DNA binding domain was localized to amino acids 167–368 by deletion analysis; the domain contains a proline-rich region and a Myc-type HLH-like motif but not the C-terminal zinc finger. NUDR represses the hnRNP A2/B1 promoter ~65–70% through binding motifs (TTC(C/G)G) in the 5′-UTR of the hnRNP A2/B1 gene, and this repression also operates on NUDR's own 5′-UTR, suggesting autoregulation.\",\n      \"method\": \"NUDR protein deletion constructs, site-specific DNA photocrosslinking, DNase I footprinting, transient transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — deletion mapping combined with photocrosslinking, footprinting, and reporter assays; multiple orthogonal methods\",\n      \"pmids\": [\"10521432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Drosophila DEAF-1 is required for early embryonic development: maternal/zygotic DEAF-1 mutations cause embryonic arrest prior to zygotic segmentation gene expression. DEAF-1 protein associates with many discrete sites on polytene chromosomes, indicating it is a broad regulator of gene expression. Overexpression causes defects in dorsal epidermis migration/closure and disrupts eye and wing development.\",\n      \"method\": \"Genetic loss-of-function (maternal/zygotic mutants), gain-of-function overexpression, polytene chromosome immunostaining\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function and gain-of-function genetics with defined phenotypic readouts plus chromosomal localization\",\n      \"pmids\": [\"12112874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Deaf-1 knockout mice display defects in neural tube closure (exencephaly), homeotic skeletal transformations (cervical vertebrae and rib cage), overlapping with but distinct from LMO4 knockout phenotypes, indicating that Deaf-1 and LMO4 function in a shared pathway controlling neural tube closure and anteroposterior skeletal patterning in vivo.\",\n      \"method\": \"Gene knockout in mice (Deaf-1 and Lmo4 null alleles), embryo and skeletal phenotypic analysis, genetic epistasis by overlapping phenotype comparison\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined phenotypic readout replicated in two independent knockout lines (Lmo4 and Deaf-1), epistatic relationship supported by overlapping phenotypes\",\n      \"pmids\": [\"14966286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DEAF-1 contains a CRM1-dependent nuclear export signal (NES) with novel leucine spacing (LXLX(6)LLX(5)LX(2)L) at amino acids 454–476 adjacent to the MYND domain; mutation of key leucines or leptomycin B treatment eliminates nuclear export. A DEAF-1/DEAF-1 self-interaction domain maps to this NES region. A second protein-protein interaction domain at aa 243–306 encompasses the SAND domain and an adjacent zinc-binding motif; mutation of conserved cysteines/histidine in the zinc motif eliminates both protein interaction and DNA binding, showing protein-protein interaction is required for DNA recognition.\",\n      \"method\": \"Fluorescent fusion protein localization, leptomycin B treatment, leucine mutagenesis, in vitro GST pull-downs, in vivo fluorescent protein interaction assay, deletion mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with in vitro and in vivo interaction assays, multiple orthogonal methods in single study\",\n      \"pmids\": [\"15161925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Deaf-1/NUDR exhibits cell-type-specific transcriptional activity at the 5-HT1A promoter C(-1019) allele: it represses transcription in serotonergic raphe RN46A cells but enhances transcription in nonserotonergic cells (SN48, SKN-SH, NG108-15). A Gal4DBD-Deaf-1 fusion protein recapitulates these opposite activities at a heterologous Gal4 element, demonstrating the activity is intrinsic to Deaf-1. Both repressor and enhancer activities require histone deacetylation (blocked by trichostatin A).\",\n      \"method\": \"Luciferase reporter assays in multiple cell lines, Gal4DBD-Deaf-1 fusion protein assays at heterologous element, trichostatin A (HDAC inhibitor) treatment\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — heterologous Gal4 domain fusion demonstrates intrinsic activity; multiple cell lines and HDAC inhibitor provide orthogonal mechanistic evidence\",\n      \"pmids\": [\"16467535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The transcriptional regulator Deaf1 controls expression of peripheral tissue antigen (PTA) genes in pancreatic lymph node stromal cells. An alternatively spliced dominant-negative Deaf1 isoform (Deaf1-Var1) suppresses PTA expression by inhibiting canonical Deaf1 transcriptional activity, and this isoform is elevated during insulitis in NOD mice and in type 1 diabetes patients.\",\n      \"method\": \"Reporter gene assays (luciferase), siRNA knockdown, gene expression profiling, RT-PCR in mouse and human lymph node samples\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional reporter assays combined with in vivo mouse model and human patient tissue, replicated across species\",\n      \"pmids\": [\"19668219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Drosophila Deaf1 is required for Toll-pathway-dependent innate immune responses: RNAi knockdown of Deaf1 reduces expression of the antifungal peptide gene Drosomycin and impairs survival after fungal (but not E. coli) infection. Epistasis analysis places Deaf1 downstream of the NF-κB factors Dorsal and Dif.\",\n      \"method\": \"Genome-wide RNAi screen, in vivo RNAi knockdown, survival assays after infection, genetic epistasis analysis\",\n      \"journal\": \"Journal of innate immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis combined with in vivo loss-of-function and pathogen challenge with specific phenotypic readout\",\n      \"pmids\": [\"20375635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Deaf-1 in vivo represses 5-HT1A autoreceptor expression in dorsal raphe (serotonergic) neurons while enhancing postsynaptic 5-HT1A heteroreceptor expression in frontal cortex. Deaf-1 knockout mice have increased 5-HT1A mRNA, protein, and positive cell counts in dorsal raphe but decreased 5-HT1A in frontal cortex, and reduced serotonin levels in raphe. A functional Deaf-1 binding site on the mouse 5-HT1A promoter was confirmed by ChIP and in vitro binding.\",\n      \"method\": \"Deaf-1 knockout mice, quantitative RT-PCR, in situ hybridization, immunofluorescence, ChIP, EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with region-specific phenotypes confirmed by multiple methods (qPCR, ISH, immunofluorescence, ChIP, EMSA)\",\n      \"pmids\": [\"22232550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DEAF1 interacts with the Ku70 (XRCC6) and Ku80 (XRCC5) subunits of the DNA-PK complex. The interaction is mediated through DEAF1's DNA binding domain and the C-terminal Bax-binding region of Ku70. DEAF1 is phosphorylated by DNA-PK in vitro in a DNA-independent manner. DEAF1 binding sites in DNA inhibit the DEAF1–Ku70 interaction, suggesting competitive regulation.\",\n      \"method\": \"GST pulldown with mass spectrometry identification, co-immunoprecipitation of epitope-tagged proteins in cells, in vitro kinase assay, EMSA\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and in vitro kinase assay in single lab; EMSA provides additional orthogonal method\",\n      \"pmids\": [\"22442688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DEAF1 regulates translation in lymph node stromal cells by controlling transcription of Eif4g3 (encoding eIF4GII). Deaf1 KO and Deaf1 silencing reduce Eif4g3 expression and increase Caspase-3-mediated eIF4GII degradation; reduced eIF4GII leads to diminished polysomal translation of multiple genes including Anpep.\",\n      \"method\": \"Deaf-1 knockout mice, siRNA silencing, RT-PCR, polysome profiling, western blotting\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO and siRNA knockdown with polysome profiling as functional readout; single lab\",\n      \"pmids\": [\"22923498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The solution NMR structure of the human DEAF-1 MYND domain (residues 501–544) reveals a ββα fold with tandem zinc-binding sites in a cross-brace topology. The MYND domain binds peptides derived from SMRT and NCoR corepressors; the binding surface mapped by NMR titrations is similar to that of AML1/ETO MYND domain, demonstrating DEAF-1 recruits corepressors through this domain.\",\n      \"method\": \"NMR spectroscopy (solution structure determination), NMR titration mapping of binding surface, peptide binding assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional validation of ligand binding; multiple orthogonal NMR methods in single rigorous study\",\n      \"pmids\": [\"23372760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DEAF1 is a Pellino1-interacting protein required for IFNβ production. DEAF1 binds the IFNβ promoter and interacts with IRF3 and IRF7. DEAF1 is required for IFNβ transcription and secretion in MEFs infected with Sendai virus or transfected with poly(I:C), and for TLR3-dependent IFNβ production. The Pellino1–DEAF1 interaction is independent of Pellino1 E3 ligase activity but is weakened by Pellino1 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation (Pellino1–DEAF1 interaction), ChIP (DEAF1 on IFNβ promoter), co-IP of DEAF1 with IRF3/IRF7, siRNA knockdown of DEAF1, ELISA for IFNβ secretion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ChIP, and siRNA KD with functional IFNβ output; multiple orthogonal methods in single study\",\n      \"pmids\": [\"23846693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A specific LMO4-binding domain in DEAF1 contains an intrinsically disordered region that directly contacts LMO4, flanked by a coiled-coil region containing the NES. The coiled-coil region can form tetramers. LMO4 modulates DEAF1 NES activity, causing nuclear accumulation of a construct containing the LMO4-interaction region of DEAF1.\",\n      \"method\": \"GST pulldowns, cell-based nuclear export assay, coiled-coil characterization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping by pulldown plus cell-based functional assay; single lab\",\n      \"pmids\": [\"22723967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The NMR solution structure of the LMO4 LIM2–DEAF1 complex shows that the intrinsically disordered LMO4-binding domain of DEAF1 becomes structured upon binding LMO4 LIM2. Yeast two-hybrid and mutagenic analysis show DEAF1 binds both LIM domains of LMO4 at the same face used by LDB1 and CtIP/RBBP8, revealing LMO4 as a competitive hub in protein interaction networks.\",\n      \"method\": \"NMR spectroscopy (solution structure of tethered complex), yeast two-hybrid, mutagenic scanning\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with mutagenic validation and yeast two-hybrid; multiple orthogonal methods in single study\",\n      \"pmids\": [\"25310299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DEAF1 preferentially binds variably spaced (6–11 nt apart), unmethylated dual CpG dinucleotide motifs (repeated TTCGGG half-sites). Cytosine methylation of a single CpG half-site or alteration of the surrounding consensus eliminates DEAF1 binding. ChIP assay confirmed endogenous DEAF1 binds the EIF4G3 promoter at a sequence matching this consensus.\",\n      \"method\": \"SELEX with anchored CpG motif, EMSA, ChIP assay for endogenous DEAF1 at EIF4G3 promoter\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SELEX-defined consensus validated by EMSA and ChIP; multiple orthogonal methods in single study\",\n      \"pmids\": [\"25531106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"All four identified de novo DEAF1 missense mutations in intellectual disability patients affect the SAND domain and impair DEAF1-dependent transcriptional regulation of the DEAF1 promoter in reporter assays. Conditional brain-specific Deaf1 knockout mice display memory deficits and increased anxiety-like behavior, establishing that SAND domain-mediated transcriptional activity is required for normal cognitive function.\",\n      \"method\": \"Luciferase reporter assays (DEAF1 promoter), conditional Deaf1 brain knockout mice (behavioral phenotyping), clinical exome sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reporter assays combined with conditional KO behavioral phenotype; replicated across four independent de novo variants\",\n      \"pmids\": [\"24726472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Inflammation and hyperglycemia independently drive alternative splicing of Deaf1 to the dominant-negative Deaf1-Var1 isoform in pancreatic lymph node stromal cells via distinct splicing factors: inflammation activates Srsf10 and hyperglycemia activates Ptbp2. Overexpression of PTBP2 and/or SRSF10 increases human DEAF1-VAR1 and reduces PTA expression.\",\n      \"method\": \"In vivo NOD mouse models (splenocyte injection, S961 insulin receptor agonist), RT-PCR for isoforms, overexpression of splicing factors in HEK293T cells, reporter assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo manipulation with splicing factor overexpression provides mechanistic pathway; single lab\",\n      \"pmids\": [\"25187368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"De novo DEAF1 missense variants in the SAND domain (e.g., p.Gly212Ser) reduce DEAF1 transcriptional repression at the DEAF1 promoter and reduce affinity to consensus DEAF1 DNA binding sequences. A NLS domain deletion variant (p.Lys305del) localizes primarily to the cytoplasm and interacts with wild-type DEAF1, consistent with dominant-negative activity via cytoplasmic sequestration.\",\n      \"method\": \"Luciferase reporter assays, immunofluorescence localization, EMSA\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays, EMSA, and localization provide three orthogonal methods; single lab\",\n      \"pmids\": [\"28940898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"De novo heterozygous DEAF1 variants within the DNA binding domain act as dominant negatives: cells overexpressing de novo variants show gene expression profiles similar to CRISPR-Cas9-mediated DEAF1 deletion. Wild-type DEAF1 rescues altered gene expression in DEAF1-deleted cells whereas de novo variants do not. Loss of Deaf1 in mouse hippocampus reduces dendritic spine density.\",\n      \"method\": \"RNA-sequencing of conditional Deaf1 KO mouse hippocampus, CRISPR-Cas9 DEAF1 deletion, overexpression rescue assays, dendritic spine imaging\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative mechanism established by rescue assay in DEAF1-null background; single lab with multiple cell models\",\n      \"pmids\": [\"35981081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DEAF1 is a FOXO-regulated transcription factor that suppresses autophagy by binding the Pik3c3 and Atg16l1 promoters and repressing their expression. DEAF1 depletion induces autophagy and impairs muscle stem cell (MuSC) survival and differentiation; DEAF1 overexpression inactivates autophagy causing protein aggregation and cell death. DEAF1 is elevated in aged and cachectic MuSCs, and its manipulation attenuates muscle atrophy.\",\n      \"method\": \"ChIP (DEAF1 binding to Pik3c3 and Atg16l1 promoters), DEAF1 depletion and overexpression in MuSCs, autophagy flux assays, in vivo mouse models (aging, cancer cachexia)\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-confirmed direct promoter binding combined with loss- and gain-of-function in vitro and in vivo with autophagy-specific functional readouts\",\n      \"pmids\": [\"38963021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DEAF1 acts as a key upstream driver of mTORC1 in aged skeletal muscle by increasing mTOR transcription. Elevated DEAF1 leads to impaired proteostasis and muscle senescence; exercise suppresses DEAF1 via FOXO activation, restoring mTORC1 balance. FOXO inhibition or Deaf1 overexpression blocks exercise-mediated restoration of muscle health.\",\n      \"method\": \"Deaf1 overexpression and depletion in mouse muscle, mTOR transcription reporter assays, mTORC1 activity measurements, FOXO inhibition, exercise intervention in mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function in vivo with mTORC1 activity readout; single lab\",\n      \"pmids\": [\"41284871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DEAF1 directly binds the RAD50 promoter via its SAND domain, upregulating RAD50 and activating the ATM DNA damage repair pathway. DEAF1 also recruits AP-2α through its MYND domain, leading to downregulation of FER tyrosine kinase, which impairs FER-mediated phosphorylation of GSDME and suppresses GSDME cleavage by caspase-3, thereby attenuating pyroptosis in multiple myeloma.\",\n      \"method\": \"ChIP (DEAF1 binding to RAD50 promoter via SAND domain), co-immunoprecipitation (DEAF1–AP-2α via MYND domain), high-throughput sequencing of DEAF1 targets, in vivo and in vitro functional assays\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with functional pathway readouts; single lab, novel mechanistic claims\",\n      \"pmids\": [\"41421151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GSK3β phosphorylates DEAF1 and modulates its repressor activity at the 5-HT1A promoter. Lithium and selective GSK3 inhibitors (CHIR-99021, AR-014418) attenuate and reverse Deaf1-mediated repression of 5-HT1A transcription at concentrations that maximally inhibit GSK3β. The Y300F point mutation in Deaf1 augments its repressor function, while other predicted phosphorylation site mutants had no effect.\",\n      \"method\": \"Luciferase reporter assays (5-HT1A promoter), GSK3β inhibitor treatments, site-directed mutagenesis of DEAF1 phosphorylation sites, TCF/LEF reporter for GSK3β activity\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis and pharmacological inhibition with reporter assays; indirect kinase evidence without direct in vitro phosphorylation shown in abstract\",\n      \"pmids\": [\"37958600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DEAF1 interacts with the transcriptional coactivator SAYP (a component of the Brahma chromatin remodeling complex) via immunoprecipitation; specific domains mediating their association were mapped. SAYP and DEAF1 are co-recruited to antimicrobial peptide (AMP) gene regions in a gene- and pathogen-specific manner in Drosophila S2 cells after immune challenge.\",\n      \"method\": \"Immunoprecipitation (SAYP–DEAF1 interaction), domain mapping, ChIP for recruitment to AMP gene loci, RNAi knockdown of SAYP and DEAF1\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping and ChIP showing co-recruitment; single study in Drosophila cell model\",\n      \"pmids\": [\"41862015\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DEAF1/NUDR is a sequence-specific transcription factor that binds unmethylated dual CpG-containing DNA motifs (TTCG/TTCGGG core) through its SAND domain, recruits corepressors (NCoR, SMRT) via its MYND domain (which has a defined ββα zinc-binding fold), interacts with LMO4, Ku70/DNA-PK, IRF3/IRF7, Pellino1, AP-2α, and SAYP, and acts as a cell-context-dependent repressor or enhancer of target gene transcription (including 5-HT1A receptor, hnRNP A2/B1, Eif4g3, Pik3c3, Atg16l1, RAD50, and mTOR); its activity is regulated by nuclear-cytoplasmic shuttling (via a CRM1-dependent NES and NLS), phosphorylation by GSK3β and DNA-PK, alternative splicing to a dominant-negative isoform, and upstream FOXO-mediated transcriptional repression, placing it at the intersection of neurodevelopment, peripheral immune tolerance, innate immunity, serotonergic neurotransmission, autophagy, and mTORC1-driven muscle aging.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DEAF1 (NUDR) is a sequence-specific transcription factor that controls programs in neurodevelopment, immune tolerance, innate immunity, serotonergic signaling, and muscle homeostasis [#0, #1, #7, #21]. It recognizes unmethylated dual CpG-containing motifs built from repeated TTCGGG half-sites variably spaced 6\\u201311 nt apart, and methylation of a single half-site abolishes binding [#1, #16]. DNA recognition is conferred by the SAND domain region; the adjacent zinc-binding motif couples protein-protein interaction to DNA binding, and a CRM1-dependent nuclear export signal together with an NLS govern its nuclear-cytoplasmic distribution [#5, #19]. A solved MYND domain adopts a \\u03b2\\u03b2\\u03b1 fold with cross-brace zinc sites that binds NCoR and SMRT corepressor peptides, providing the structural basis for transcriptional repression, which depends on histone deacetylation [#12, #6]. DEAF1 acts as a cell-context-dependent repressor or activator: it represses the hnRNP A2/B1 promoter and its own promoter, represses the 5-HT1A autoreceptor in raphe neurons while enhancing it in non-serotonergic cells, and controls peripheral tissue antigen expression in lymph node stromal cells, where an alternatively spliced dominant-negative isoform (Deaf1-Var1) suppresses its activity [#2, #6, #7, #9]. Through an intrinsically disordered region that becomes structured on binding LMO4 LIM domains, DEAF1 engages LMO4 as a competitive interaction hub that modulates its nuclear export [#14, #15]. In innate immunity it binds the IFN\\u03b2 promoter and interacts with IRF3/IRF7 and Pellino1 to drive antiviral IFN\\u03b2 production [#13]. In muscle, DEAF1 is a FOXO-regulated factor that represses the autophagy genes Pik3c3 and Atg16l1 and drives mTOR transcription, becoming elevated in aged and cachectic muscle stem cells [#21, #22]. De novo SAND-domain and NLS missense/deletion variants cause an intellectual disability disorder by impairing DNA binding and transcriptional regulation and acting as dominant negatives, with conditional brain knockout mice showing memory deficits, anxiety, and reduced dendritic spine density [#17, #19, #20].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established DEAF1 as a sequence-specific DNA-binding cofactor by showing it binds a defined site in the Deformed homeotic response element and is required for Deformed-dependent activation.\",\n      \"evidence\": \"Affinity isolation from Drosophila nuclear extracts with response-element mutagenesis and embryonic reporter assays\",\n      \"pmids\": [\"8617243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian role not addressed\", \"Domain responsible for binding not yet mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the mammalian DEAF1/NUDR consensus motif and showed nuclear localization is required for transcriptional activity, framing it as a regulated nuclear transcription factor.\",\n      \"evidence\": \"SELEX, EMSA, DNase I footprinting, NLS mutagenesis and reporter assays\",\n      \"pmids\": [\"9773984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous target genes not yet identified\", \"Mechanism of activation vs repression unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Localized the DNA-binding domain by deletion mapping and demonstrated DEAF1 represses the hnRNP A2/B1 promoter and its own 5'-UTR, introducing autoregulation.\",\n      \"evidence\": \"Deletion constructs, photocrosslinking, footprinting and reporter assays\",\n      \"pmids\": [\"10521432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor machinery not identified\", \"Structural basis of binding unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed DEAF1 is essential for early development and broadly chromatin-associated, expanding it from a single-gene cofactor to a global regulator.\",\n      \"evidence\": \"Drosophila loss/gain-of-function genetics and polytene chromosome immunostaining\",\n      \"pmids\": [\"12112874\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes in vivo undefined\", \"Mammalian developmental role not tested here\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the in vivo mammalian developmental role and a shared pathway with LMO4 in neural tube closure and skeletal patterning.\",\n      \"evidence\": \"Deaf-1 and Lmo4 knockout mice with embryo and skeletal phenotyping\",\n      \"pmids\": [\"14966286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular nature of Deaf1-LMO4 interaction not yet structural\", \"Target genes mediating phenotypes unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved domain architecture controlling localization and DNA binding, showing a CRM1-dependent NES, a self-interaction region, and that protein interaction at the SAND/zinc motif is required for DNA recognition.\",\n      \"evidence\": \"Fusion protein localization, leptomycin B, leucine/cysteine mutagenesis, GST pulldowns and in vivo interaction assays\",\n      \"pmids\": [\"15161925\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological partners at the interaction domain not all identified\", \"Regulation of shuttling not linked to signaling\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that DEAF1 transcriptional activity is intrinsic and cell-type-dependent (repressor vs enhancer) at the 5-HT1A promoter and requires histone deacetylation.\",\n      \"evidence\": \"Multi-cell-line luciferase assays, Gal4DBD fusion at heterologous element, trichostatin A treatment\",\n      \"pmids\": [\"16467535\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of cell-type-specific cofactors switching activity unknown\", \"In vivo serotonergic consequence not yet shown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified DEAF1 control of peripheral tissue antigen expression in lymph node stroma and a dominant-negative splice isoform elevated in autoimmune diabetes, linking it to immune tolerance.\",\n      \"evidence\": \"Reporter assays, siRNA, expression profiling and RT-PCR in mouse and human tissue\",\n      \"pmids\": [\"19668219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Splicing regulation of Var1 not yet defined\", \"Direct PTA promoter targets not all mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed Drosophila Deaf1 downstream of NF-\\u03baB factors in Toll-dependent antifungal immunity, establishing an innate immune function.\",\n      \"evidence\": \"Genome-wide RNAi screen, in vivo knockdown, infection survival and epistasis\",\n      \"pmids\": [\"20375635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian innate immune role not addressed here\", \"Mechanism of antimicrobial gene induction unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the LMO4-binding region as an intrinsically disordered segment flanked by a tetramer-forming coiled-coil, and showed LMO4 modulates DEAF1 nuclear export.\",\n      \"evidence\": \"GST pulldowns, cell-based export assay and coiled-coil characterization\",\n      \"pmids\": [\"22723967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural detail of complex not yet resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected DEAF1 to the DNA-PK machinery, showing Ku70/Ku80 binding and DNA-PK phosphorylation of DEAF1 with DNA competing for the interaction.\",\n      \"evidence\": \"GST pulldown/MS, reciprocal Co-IP, in vitro kinase assay and EMSA\",\n      \"pmids\": [\"22442688\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of phosphorylation unresolved\", \"Single lab without in vivo validation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined a downstream translational output of DEAF1 by showing it transcriptionally controls Eif4g3/eIF4GII and thereby polysomal translation in lymph node stroma.\",\n      \"evidence\": \"Knockout/siRNA, RT-PCR, polysome profiling and western blot\",\n      \"pmids\": [\"22923498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality beyond stromal cells unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked DEAF1 to serotonergic neurotransmission in vivo, showing region-specific repression of the 5-HT1A autoreceptor and enhancement of the heteroreceptor.\",\n      \"evidence\": \"Knockout mice with qPCR, ISH, immunofluorescence, ChIP and EMSA\",\n      \"pmids\": [\"22232550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavioral/affective consequences not directly tested\", \"Switch mechanism between brain regions unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided the MYND domain structure and showed it recruits NCoR/SMRT corepressors, defining the structural basis of DEAF1 repression.\",\n      \"evidence\": \"Solution NMR structure, titration mapping and peptide binding\",\n      \"pmids\": [\"23372760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor recruitment not validated on endogenous targets\", \"Activator mechanism still unexplained\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established a positive innate immune role in mammals, with DEAF1 binding the IFN\\u03b2 promoter and partnering IRF3/IRF7 and Pellino1 to drive IFN\\u03b2 production.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP, siRNA and IFN\\u03b2 ELISA in virus/poly(I:C)-challenged MEFs\",\n      \"pmids\": [\"23846693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of Pellino1 phosphorylation in vivo not resolved\", \"How DEAF1 cooperates with IRFs structurally unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Solved the LMO4 LIM2\\u2013DEAF1 complex, showing disorder-to-order folding on binding and that DEAF1 competes with LDB1 and CtIP for LMO4, defining LMO4 as a shared interaction hub.\",\n      \"evidence\": \"NMR structure of tethered complex, yeast two-hybrid and mutagenic scanning\",\n      \"pmids\": [\"25310299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional outcome of LMO4 competition on target genes unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Refined the DNA recognition code to variably spaced unmethylated dual CpG motifs, establishing methylation sensitivity and an endogenous EIF4G3 target.\",\n      \"evidence\": \"Anchored-CpG SELEX, EMSA and ChIP at the EIF4G3 promoter\",\n      \"pmids\": [\"25531106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide occupancy not mapped\", \"Link of methylation sensitivity to physiology untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established DEAF1 as an intellectual disability gene, with SAND-domain de novo missense variants impairing transcriptional activity and brain-specific knockout causing cognitive deficits.\",\n      \"evidence\": \"Exome sequencing, reporter assays and conditional brain knockout behavioral phenotyping\",\n      \"pmids\": [\"24726472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise neuronal targets driving cognition unknown\", \"Dominant vs recessive mechanism not yet resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined how the dominant-negative Deaf1-Var1 isoform is generated, identifying inflammation- and hyperglycemia-driven splicing via Srsf10 and Ptbp2.\",\n      \"evidence\": \"NOD mouse models, isoform RT-PCR and splicing factor overexpression with reporters\",\n      \"pmids\": [\"25187368\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct splicing factor binding sites not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended the disease mechanism by showing SAND-domain variants reduce DNA-binding affinity and an NLS deletion variant sequesters DEAF1 in the cytoplasm and binds wild-type protein, supporting dominant-negative action.\",\n      \"evidence\": \"Reporter assays, EMSA and immunofluorescence localization\",\n      \"pmids\": [\"28940898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative effect not yet shown at endogenous targets\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Confirmed the dominant-negative mechanism transcriptome-wide, showing de novo DNA-binding-domain variants phenocopy DEAF1 deletion and fail to rescue, and linked Deaf1 loss to reduced dendritic spine density.\",\n      \"evidence\": \"Conditional KO hippocampal RNA-seq, CRISPR deletion, rescue assays and spine imaging\",\n      \"pmids\": [\"35981081\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal target genes for spine phenotype not pinpointed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Added phospho-regulation of DEAF1 by GSK3\\u03b2 at the 5-HT1A promoter, with GSK3 inhibitors reversing repression and the Y300F mutant augmenting repressor function.\",\n      \"evidence\": \"Reporter assays with GSK3 inhibitors and phosphosite mutagenesis\",\n      \"pmids\": [\"37958600\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in vitro phosphorylation not demonstrated\", \"In vivo relevance to behavior untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined DEAF1 as a FOXO-regulated autophagy repressor that directly represses Pik3c3 and Atg16l1, controlling muscle stem cell survival and elevated in aging and cachexia.\",\n      \"evidence\": \"ChIP, loss/gain-of-function in MuSCs, autophagy flux assays and in vivo aging/cachexia models\",\n      \"pmids\": [\"38963021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FOXO\\u2013DEAF1 promoter regulation not structurally defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Positioned DEAF1 as an upstream driver of mTORC1 in aged muscle by increasing mTOR transcription, with exercise suppressing it via FOXO to restore proteostasis.\",\n      \"evidence\": \"Deaf1 gain/loss in muscle, mTOR reporter and mTORC1 activity assays, FOXO inhibition and exercise intervention\",\n      \"pmids\": [\"41284871\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DEAF1 occupancy of the mTOR promoter not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealed a cancer-relevant dual function in which SAND-mediated RAD50 activation engages ATM repair while MYND-mediated AP-2\\u03b1 recruitment suppresses GSDME pyroptosis in multiple myeloma.\",\n      \"evidence\": \"ChIP, Co-IP, high-throughput target sequencing and functional assays in vitro and in vivo\",\n      \"pmids\": [\"41421151\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality beyond multiple myeloma unknown\", \"Single lab with novel claims\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected DEAF1 to a chromatin remodeling coactivator, showing SAYP (Brahma complex) interaction and pathogen-specific co-recruitment to antimicrobial peptide loci.\",\n      \"evidence\": \"Co-IP with domain mapping, ChIP and RNAi in Drosophila S2 cells\",\n      \"pmids\": [\"41862015\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mammalian conservation of SAYP interaction untested\", \"Single study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single sequence-specific factor switches between repressor and activator outputs across cell types and biological processes remains the central open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide occupancy map integrating contexts\", \"Cofactor switch governing activation vs repression undefined\", \"Integration of phosphorylation, splicing, and shuttling into a unified regulatory model lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 6, 7, 9, 17, 21]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 2, 16, 17, 19]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [12, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 6, 9, 16, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 13]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 17, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"LMO4\", \"XRCC6\", \"XRCC5\", \"IRF3\", \"IRF7\", \"PELI1\", \"TFAP2A\", \"NCOR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}